RevistaLab
According to 1Q26 data, only a few submarkets of the greater Boston area have maintained an occupancy above 90%. Two of the smallest submarkets, South 495 and the New Hampshire part of the Boston CBSA are technically . . .
Direct vacancy in life-science real estate has begun to stabilize over the past several quarters, but sublease availability continues to rise. Rising sublease space signals potential tenant turnover and underscores …
When it comes to life science, the Midwest is often overshadowed by the core coastal hubs. However, the Midwest contains a strong ecosystem built on industrial infrastructure and solid talents pools. Revista is tracking over 56 million . . .
After the wave of speculative life science construction in recent years, all eyes are on fundamentals to see when meaningful recovery will occur. While overall there is no confirmation that …
New life science construction has bounced off its low point reached in 2Q25. At that time 10.4 million square feet had broken ground within the twelve months prior. By the final quarter of the year, the trailing twelve-month total moved up to . . .
After $19.7B traded in 2021, transaction activity has slowed each year after and has established a current bottom in 2025 with just $3.8 billion traded. But activity appears to be picking up. So far in 2026 . . .
he life science ecosystem in Houston is one of the strongest in the country, and this thriving environment is now the 11th largest life science real estate market we track. With slightly under 5 million square feet of space, Houston is a scale below the three primary hubs (Boston/San Fran/San Diego) but is now . . .
Over the past two years, there has been a trend of increasing sublease listings in the life science sector. For investor-owned life science properties, the chart below displays the square footage that is available for sublease, and the two occupancy rates that depend on whether . . .
U.S. life science manufacturing has had strong tailwinds for more than five years, starting with pandemic-related supply chain disruptions and continuing with the recent policy changes that encourage onshoring. The …